Reach Neuro has welcomed Jennifer Ernst as its new Chief Executive Officer. Ernst is an experienced CEO and strategist who has built and commercialized deep technology in regulated markets. As CEO of Tivic Health (Nasdaq: TIVC, now Valion Bio), she led a bioelectronic medicine company from founding to IPO, taking an FDA-cleared product from concept to commercialization. Earlier, as Chief Strategy Officer of Thin Film Electronics ASA, an Oslo-listed hardware company, she shaped the strategy and go-to-market for a public company reset, launching four product lines and building the company to a half-billion-dollar market cap.
Reach Neuro welcomes Jennifer Ernst as Chief Executive Officer
